Lv5
1480 积分 2022-03-23 加入
Safety, tolerability, and pharmacokinetic characteristics of a sustained-release formulation of ropivacaine (QP-6211) in healthy Chinese participants: a dose-escalation phase I clinical trial
2天前
已完结
Safety, tolerability, and pharmacokinetic characteristics of a sustained-release formulation of ropivacaine (QP-6211) in healthy Chinese participants: a dose-escalation phase I clinical trial
2天前
已完结
The bradykinin-1 receptor antagonist fulmetibant in patients with diabetic neuropathic pain: the randomized, crossover, placebo-controlled, double-blind, phase 2a BRADiNP study
2个月前
已完结
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
4个月前
已完结
皖公网安备34019202002308
